Acasti Pharma Balance Sheet Health
Financial Health criteria checks 6/6
Acasti Pharma has a total shareholder equity of $64.7M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $76.2M and $11.5M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
Interest coverage ratio | n/a |
Cash | US$25.11m |
Equity | US$64.68m |
Total liabilities | US$11.51m |
Total assets | US$76.19m |
Recent financial health updates
We're Keeping An Eye On Acasti Pharma's (NASDAQ:ACST) Cash Burn Rate
Apr 20Will Acasti Pharma (NASDAQ:ACST) Spend Its Cash Wisely?
Nov 14We're Not Very Worried About Acasti Pharma's (NASDAQ:ACST) Cash Burn Rate
May 10Recent updates
We're Keeping An Eye On Acasti Pharma's (NASDAQ:ACST) Cash Burn Rate
Apr 20Will Acasti Pharma (NASDAQ:ACST) Spend Its Cash Wisely?
Nov 14We're Not Very Worried About Acasti Pharma's (NASDAQ:ACST) Cash Burn Rate
May 10Acasti Pharma GAAP EPS of -$0.10
Aug 11Acasti inks deal for Grace Therapeutics, shares surge
May 07Acasti Pharma issues clarification on trading activity
Dec 23Acasti Pharma EPS in-line
Nov 16Financial Position Analysis
Short Term Liabilities: ACST's short term assets ($26.9M) exceed its short term liabilities ($1.8M).
Long Term Liabilities: ACST's short term assets ($26.9M) exceed its long term liabilities ($9.7M).
Debt to Equity History and Analysis
Debt Level: ACST is debt free.
Reducing Debt: ACST has no debt compared to 5 years ago when its debt to equity ratio was 5.8%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: ACST has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: ACST has sufficient cash runway for 1.7 years if free cash flow continues to grow at historical rates of 5.1% each year.